Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • CEO to be named soon...

    CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture

    Written by Ruby Khatun Khatun Published On 2018-06-11T09:45:09+05:30  |  Updated On 11 Jun 2018 9:45 AM IST
    CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture

    Berkshire Hathaway Inc, Amazon.com Inc and JPMorgan Chase & Co within the next two weeks will likely name a chief executive for their joint venture aimed at lowering the cost of healthcare, billionaire investor Warren Buffett said in an interview aired on Thursday on CNBC.


    Buffett, who is Berkshire Hathaway’s chairman, and JPMorgan Chief Executive Jamie Dimon said in the interview that they had selected a person for the healthcare venture’s top job.


    Famed for his love of junk food, Buffett has described U.S. healthcare costs as a “tapeworm” on American businesses, hurting their ability to compete with rivals in other countries. Last month, he said the goal is to challenge the entire healthcare industry, not individual segments.


    “We’ve basically reached an agreement,” Buffett said. “We should have an announcement on that matter within maybe two weeks.”


    While there is no guarantee the venture between Amazon.com, Berkshire, and JPMorgan, which collectively employ more than 1 million people, will succeed in lowering costs, Buffett said it was well positioned to try.


    “The resistance will be unbelievable, and if we fail, at least we tried,” Buffett said last month.


    Amazon’s size and reputation as a disruptor prompted investors to sell shares of companies that might be hurt by the venture when it was announced in January.


    These included drugmakers, health insurers and pharmacy benefit managers (PBMs), such as CVS Health Corp and Express Scripts Holding Co.





    Reporting by Trevor Hunnicutt; Editing by Bernadette Baum and Bill Berkrot)




    AmazonAmazon.comBerkshireBerkshire HathawayCEOchief executiveCVS Health CorpJamie Dimonjoint ventureJPMorganWarren Buffett
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok